ICH adopted E6(R3) Good Clinical Practice guideline on 6Jan2025!
This revision provides updates to the prior revision and clarifies a number of responsibilities for sponsors, investigators and IRBs, plus a number of other considerations for anyone supporting human clinical trials.
https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf
#GCP #GoodClinicalPractice #ICH #E6_R3
------------------------------
Mark Arnold Ph.D., FAAPS
Westampton, NJ
[email protected]Bioanalytical Solution Integration
LinkedIn:
https://www.linkedin.com/in/markearnoldphd/Website & Blog: Bioanalysis & Biomarkers <bioanalysisandbiomarkers.blogspot.com>
------------------------------
</bioanalysisandbiomarkers.blogspot.com>